|
Volumn 8, Issue 10, 2013, Pages
|
Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDE;
ENZYME INHIBITOR;
N (N (3,5 DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE TERT BUTYL ESTER;
N-(N-(3,5-DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE TERT-BUTYL ESTER;
NOTCH1 PROTEIN, MOUSE;
NOTCH1 RECEPTOR;
PROTEIN P53;
SECRETASE;
ANIMAL;
ARTICLE;
BILE DUCT CARCINOMA;
BILE DUCT TUMOR;
CELL MOTION;
CELL PROLIFERATION;
DISEASE MODEL;
DRUG ANTAGONISM;
DRUG EFFECT;
EPITHELIAL MESENCHYMAL TRANSITION;
EPITHELIUM CELL;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
INFANT;
INTRAHEPATIC BILE DUCT;
MALE;
METABOLISM;
MOUSE;
PATHOLOGY;
PROTEIN TERTIARY STRUCTURE;
SIGNAL TRANSDUCTION;
TUMOR CELL LINE;
TUMOR INVASION;
AMYLOID PRECURSOR PROTEIN SECRETASES;
ANIMALS;
BILE DUCT NEOPLASMS;
BILE DUCTS, INTRAHEPATIC;
CELL LINE, TUMOR;
CELL MOVEMENT;
CELL PROLIFERATION;
CHOLANGIOCARCINOMA;
DIPEPTIDES;
DISEASE MODELS, ANIMAL;
ENZYME INHIBITORS;
EPITHELIAL CELLS;
EPITHELIAL-MESENCHYMAL TRANSITION;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
INFANT;
MALE;
MICE;
NEOPLASM INVASIVENESS;
PROTEIN STRUCTURE, TERTIARY;
RECEPTOR, NOTCH1;
SIGNAL TRANSDUCTION;
TUMOR SUPPRESSOR PROTEIN P53;
|
EID: 84905206968
PISSN: None
EISSN: 19326203
Source Type: Journal
DOI: 10.1371/journal.pone.0077433 Document Type: Article |
Times cited : (50)
|
References (0)
|